--(BUSINESS WIRE)-- The threat of biological agents such as anthrax is real. Contracting for countermeasures, the U.S. government works with industry in its preparedness efforts to protect the population. Following opening remarks by Dr. Robin Robinson, BARDA Director, learn about navigating the contracting process and working with the U.S. government in identifying and fulfilling medical countermeasure development and procurement requirements.
|
Who: |
Barbara Solow, Ph.D. |
|||
|
VP External Development |
||||
|
Emergent BioSolutions |
||||
|
What: |
Plenary Session: Working with the U.S. Government |
|||
|
When: |
June 7, 2011, 8:30 – 10:00 am Pacific |
|||
|
Where: |
Meeting Room 16 A & B |
|||
|
San Diego Convention Center |
||||
|
111 West Harbor Drive |
||||
|
San Diego, CA 92101 |
||||
About Emergent BioSolutions Inc.
Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology, and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.
CONTACT:
Emergent BioSolutions
Tracey Schmitt, 301-795-1800
[email protected]
KEYWORDS: United States North America California
INDUSTRY KEYWORDS: Health Biotechnology Defense Other Defense
MEDIA:
| Logo |